AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Denmark: CagriSema has demonstrated superior weight loss in adults with obesity or overweight and type 2 diabetes in the ...

With Roche's latest deal, a new contender enters the obesity space, which could threaten NVO and LLY's dominance in the ...

Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche RHHBY ...

European stocks look like newly good investments amid Trump's tariff war and US economic unpredictabilities. European defense stocks are particularly appealing.

By 2020, Chouinard’s discomfort with his ownership of the lucrative outdoor apparel brand was ramping up. While Patagonia has ...

Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner ...

(1:00) - Are We Heading Towards A Recession?(7:10) - What Can We Expect From The Fed The Next Few Months?(12:30) - How Should You Position Your Portfolio Right Now?(17:40) - Top Stocks To Keep On Your ...

Partly cloudy. Very high chance of showers in the west, medium chance elsewhere. The chance of a thunderstorm, possibly severe. Heavy falls possible inland. Winds northwest to southwesterly 15 to 20 ...